Hualan Biological Bacterin Inc.
SHZ: 301207.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Wenjue An
- Employees
- 748
- Headquarters
- Xinxiang, China
- IPO year
- 2022
- Market cap
- CN¥12.6B
- Website
- https://www.hualanbacterin.com
Loading 301207…
Loading profile data…Frequently asked questions about 301207
What does Hualan Biological Bacterin Inc. (301207.SZ) do?
Hualan Biological Bacterin Inc. engages in the research, development, production, and sale of vaccines in China. It offers It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, H1N1 influenza virus split vaccines, ACYW135 meningococcal polysaccharide plague vaccines, recombinant hepatitis B vaccines, and group A...
Where does 301207.SZ trade?
Hualan Biological Bacterin Inc. (301207.SZ) trades on the Shenzhen Stock Exchange.
What sector is 301207.SZ in?
Hualan Biological Bacterin Inc. (301207.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Hualan Biological Bacterin Inc.?
Wenjue An is the chief executive officer of Hualan Biological Bacterin Inc. (301207.SZ).
Where is Hualan Biological Bacterin Inc. headquartered?
Hualan Biological Bacterin Inc. is headquartered in China.
Does 301207.SZ pay a dividend?
Yes — Hualan Biological Bacterin Inc. (301207.SZ) paid a trailing twelve-month dividend of CNY 0.80 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 301207.SZ go public?
Hualan Biological Bacterin Inc. (301207.SZ) completed its initial public offering in 2022.